Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
AIDS (London, England)|September 4, 1998
Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysisA M Bayoumi, D A RedelmeierQuality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 5, 1999
Economic methods for measuring the quality of life associated with HIV infectionA M Bayoumi, D A RedelmeierMedical Decision Making : an International Journal of the Society for Medical Decision Making|November 4, 2000
Decision analysis with cumulative prospect theoryA M Bayoumi, D A RedelmeierEuropean Journal of Neurology|October 14, 2018
EQ-5D-5L and SF-6D health utility index scores in patients with myasthenia gravisC Barnett, V Bril, A M BayoumiClinical Pharmacology and Therapeutics|July 17, 2007
Current assessment of risk-benefit by regulators: is it time to introduce decision analyses?D A Hughes, A M Bayoumi, M PirmohamedJournal of the National Cancer Institute|November 4, 2000
Cost-effectiveness of androgen suppression therapies in advanced prostate cancerA M Bayoumi, A D Brown, A M GarberKidney International|January 13, 2006
The impact of home nocturnal hemodialysis on end-stage renal disease therapies: a decision analysisP A McFarlane, A M Bayoumi, A Pierratos, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2001
The cost effectiveness of voluntary prenatal and routine newborn HIV screening in the United StatesG S Zaric, A M Bayoumi, M L Brandeau, et al.American Journal of Respiratory and Critical Care Medicine|April 1, 1997
Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patientsD A Redelmeier, A M Bayoumi, R S Goldstein, et al.AIDS Care|March 17, 2007
Adverse quality of life consequences of antiretroviral medicationsL Y Park-Wyllie, C S Strike, T Antoniou, et al.Pageof 2